Pacira | PCRX - DÍVIDA





DÍVIDA Alterar Data
Assertio Holdings USD 38.87M 615K 2023-09
Astellas Pharma JPY 831.43B 83.94B 2025-03
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Cara Therapeutics USD 0 0 2025-03
Coherus Biosciences USD 294.92M 1.25M 2025-03
Heron Therapeutics USD 149.65M 157K 2024-09
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
J&J USD 47.93B 2.14B 2025-12
Ligand Pharmaceuticals USD 451.49M 494K 2025-12
Nektar Therapeutics USD 0 0 2022-06
Novo Nordisk DKK 118.72B 61.75B 2025-03
Omeros USD 442.16M 199K 2023-09
Pacira USD 367.66M 4.53M 2026-03
Perrigo USD 3.64B 4.5M 2025-12
Pfizer USD 63.73B 231M 2026-03
Supernus Pharmaceuticals USD 40.98M 1.23M 2025-12
Teva Pharmaceutical Industries USD 17.09B 21M 2025-12
Xeris Pharmaceuticals USD 257.65M 431K 2025-09
Xoma USD 120.79M 3.27M 2024-06
Zoetis USD 9.24B 1.96B 2025-12